These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 1630860)

  • 41. Clonal expansion of T cells and HIV genotypes in microdissected splenic white pulps indicates viral replication in situ and infiltration of HIV-specific cytotoxic T lymphocytes.
    Cheynier R; Henrichwark S; Hadida F; Pelletier E; Oksenhendler E; Autran B; Wain-Hobson S
    Adv Exp Med Biol; 1995; 374():173-82. PubMed ID: 7572391
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Analysis of human immunodeficiency virus-infected tissues by amplification and in situ hybridization reveals latent and permissive infections at single-cell resolution.
    Embretson J; Zupancic M; Beneke J; Till M; Wolinsky S; Ribas JL; Burke A; Haase AT
    Proc Natl Acad Sci U S A; 1993 Jan; 90(1):357-61. PubMed ID: 8419941
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Human retroviruses: a decade of discovery and link with human disease.
    Gallo RC
    J Infect Dis; 1991 Aug; 164(2):235-43. PubMed ID: 1677372
    [No Abstract]   [Full Text] [Related]  

  • 44. Conserved molecular signatures in gp120 are associated with the genetic bottleneck during simian immunodeficiency virus (SIV), SIV-human immunodeficiency virus (SHIV), and HIV type 1 (HIV-1) transmission.
    Gonzalez MW; DeVico AL; Lewis GK; Spouge JL
    J Virol; 2015 Apr; 89(7):3619-29. PubMed ID: 25589663
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cytokine regulation of HIV expression.
    Fauci AS
    Lymphokine Res; 1990; 9(4):527-31. PubMed ID: 2090879
    [TBL] [Abstract][Full Text] [Related]  

  • 46. HIV evolution and escape.
    Richman DD; Little SJ; Smith DM; Wrin T; Petropoulos C; Wong JK
    Trans Am Clin Climatol Assoc; 2004; 115():289-303. PubMed ID: 17060974
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Chemotherapy of human immunodeficiency virus (HIV) infection: anti-HIV agents targeted at early stages in the virus replicative cycle.
    De Clercq E
    Biomed Pharmacother; 1996; 50(5):207-15. PubMed ID: 8949401
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The molecular biology of HIV. Insights into pathogenesis and targets for therapy.
    Zeichner SL
    Clin Perinatol; 1994 Mar; 21(1):39-73. PubMed ID: 8013186
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [ATL and AIDS].
    Matsuoka M
    Rinsho Ketsueki; 2003 May; 44(5):294-301. PubMed ID: 12822403
    [No Abstract]   [Full Text] [Related]  

  • 50. Opportunistic events and p17 expression in the bone marrow of human immunodeficiency virus-infected patients.
    Wiley EL; Nightingale SD
    J Infect Dis; 1994 Mar; 169(3):617-20. PubMed ID: 8158036
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Virology. Weapons of mutational destruction.
    KewalRamani VN; Coffin JM
    Science; 2003 Aug; 301(5635):923-5. PubMed ID: 12920286
    [No Abstract]   [Full Text] [Related]  

  • 52. Strategies used by human immunodeficiency virus that allow persistent viral replication.
    Desrosiers RC
    Nat Med; 1999 Jul; 5(7):723-5. PubMed ID: 10395309
    [No Abstract]   [Full Text] [Related]  

  • 53. Multifactorial nature of human immunodeficiency virus disease: implications for therapy.
    Fauci AS
    Science; 1993 Nov; 262(5136):1011-8. PubMed ID: 8235617
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Molecular targets of gene transfer therapy for HIV infection.
    Buchschacher GL
    JAMA; 1993 Jun; 269(22):2880-6. PubMed ID: 8497092
    [No Abstract]   [Full Text] [Related]  

  • 55. Roles of microRNAs and long-noncoding RNAs in human immunodeficiency virus replication.
    Rice AP
    Wiley Interdiscip Rev RNA; 2015; 6(6):661-70. PubMed ID: 26394053
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cellular topoisomerase I activity associated with HIV-1.
    Jardine D; Tachedjian G; Locarnini S; Birch C
    AIDS Res Hum Retroviruses; 1993 Dec; 9(12):1245-50. PubMed ID: 8142141
    [TBL] [Abstract][Full Text] [Related]  

  • 57. HIV and GB virus C--can two viruses be better than one?
    Pomerantz RJ; Nunnari G
    N Engl J Med; 2004 Mar; 350(10):963-5. PubMed ID: 14999105
    [No Abstract]   [Full Text] [Related]  

  • 58. Diversity and variation in human immunodeficiency virus: implications for immune control.
    Ramsay AJ
    Immunol Cell Biol; 1992 Jun; 70 ( Pt 3)():215-21. PubMed ID: 1452223
    [No Abstract]   [Full Text] [Related]  

  • 59. [HIV superinfection].
    Kishi M; Ikuta K
    Nihon Rinsho; 1993 Sep; 51 Suppl():598-603. PubMed ID: 8271445
    [No Abstract]   [Full Text] [Related]  

  • 60. Molecular investigation of human immunodeficiency virus (HIV) infection in a patient of an HIV-infected surgeon.
    Holmes EC; Zhang LQ; Simmonds P; Rogers AS; Brown AJ
    J Infect Dis; 1993 Jun; 167(6):1411-4. PubMed ID: 8501332
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.